SGMO icon

Sangamo Therapeutics
SGMO

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5.5
1,002% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Gena Wang
100% 1-yr SGMO win rate
7 Nov ‘25 27 days ago
HC Wainwright & Co
HC Wainwright & Co
Patrick Trucchio
38% 1-yr SGMO win rate
4 Sep ‘25 3 months ago